Albany Molecular Research, Inc. has signed a stock purchase agreement to acquire ComGenex, a privately held drug discovery service company in Budapest, Hungary. Founded in 1992, ComGenex provides contract chemistry services to the pharma and biotech industries, integrating parallel synthesis with computational chemistry to create unique small molecules with drug-like characteristics. The company has also developed novel applications in the areas of chemical genomics and target identification. ...